Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR1,110 at Citi Nov 6, 2024 11:24PM
Citi Reiterates Sell Rating on Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) Jun 28, 2024 12:30AM
Citius Pharmaceuticals (CTXR) Acquires Dr. Reddy's (RDY) Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indicatio Sep 7, 2021 07:34AM
Citius Pharmaceuticals Acquires Dr. Reddy's Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications Sep 7, 2021 07:30AM
Citi Upgrades Dr. Reddy's Laboratories (RDY) to Buy Jan 9, 2020 10:59AM


Jan 17, 2019 10:45AM Citi Downgrades Dr. Reddy's Laboratories (RDY) to Sell
May 10, 2010 08:06AM Citi Downgrades Dr. Reddy's (RDY) to Hold
Mar 7, 2008 09:25AM Pre-Open Movers 03/07: Reddy Ice Holdings (FRZ) Sinks On Fed Search Warrant, Ambac (ABK) Down On Offering
Mar 7, 2008 07:59AM Citi Downgrades Dr. Reddy's (RDY) to Hold